CC BY
20
К^и/1ребёнка
КёУчна пед1атр1я / Clinical Pediatrics
UDC 616.24-002-02:612.017.11:577.112]-053.3/.4 DOI: 10.22141/2224-0551.12.2.2017.99762
G.O. Lezhenko1, A.E. Abaturov2, O.E. Pashkova1, H.V. Kraynya1
1Zaporizhia State Medical University, Zaporizhzhia, Ukraine
2State Institution "Dnipropetrovsk Medical Academy", Dnipro, Ukraine
The role of endogenous antibacterial peptides in pneumonia occurrence among children of young age
For cite: Zdorov'ye Rebenka. 2017;12:104-8. doi: 10.22141/2224-0551.12.2.2017.99762
Abstract. The comprehensive examination included 204 children with community-acquired pneumonia aged 2 months to 3 years. It was found that in young children with community-acquired pneumonia, the main etiologic factor is bacteria Streptococcus pneumoniae (36.8 %). The content of endogenous antimicrobial peptides was identified in the serum of 20 young children with pneumonia and in 17 children in the control group. It is proved that the development of pneumonia in young children occurs on the background of the reduction in the blood serum levels ofj-defensin and cathelicidin LL-37. The lowest values ofLL-37were identified in children with pneumonia caused by Streptococcus pneumoniae. The analysis of the content of vitamin D metabolites in the serum showed that in children with pneumonia, concentration of 25-hydroxyvitamin D was 1.4 times lower compared with healthy children (p < 0.05). Established deficiency of vitamin D metabolites in young children with community-acquired pneumonia serves as an important pathogenetic factor for cathelicidin LL-37 deficiency in the blood serum, which was confirmed by 3.7-times decrease in the percentage of LL-37 compared with vitamin D metabolites in this cohort of patients.
Keywords: community-acquired pneumonia; j-defensin; cathelicidin LL-37; 25-hydroxyvitamin D; young children
Introduction
Acute respiratory infections of lower respiratory tracts — is a leading reason of child-under 5 years disease incidence in the world and makes up 34—40 occurrences among 1000 children a year [1]. Pneumonia is also a leading reason for child of young age deaths in the world. Every year it takes approximately 1,4 million children under 5 years old [2]. An important role in supporting a barrier function of respiratory epithelium and, as a cause, in avoidance of inflammatory diseases of respiratory tracts, play endogenous opiate peptides, in particular: defensin and cathelicidin LL-37, which are secreted by epithelial cell, neutrophils, monocytes and lymphocytes [3, 4]. These peptides are non-specific factors of humoral immunity and display a line of actions, including endotoxin-neutra-lizing and immunomodulatory action, and also providing protection against a wide spectrum of microorga-
nisms: gram-negative and grampositive bacteria, fungus, viruses and the simplest [5]. The relevance of antimicrobial peptides to protect the host's organism from infection was illustrated on animal models and acknowledged by clinical observations, which demonstrate the change of their expression in cases of different diseases of respiratory tract [6]. The activation of NEUTS during infectious and inflammatory processes leads to a quick release of defensins, which later are found in plasma and other organism liquids. Cytokine and defensin activation disorder leads to penetration of originator even in small amounts of it [7].
Cathelicidin has an important role in an innate immunity in protection from bacterial infections, developing antimicrobial activity against gram-negative and gram-positive bacteria, fungus, some viruses and the simplest, and also doing a synergetic antimicrobial effect along with the defensins. The change of concentration
© «Child's Health», 2017 © «Здоров'я дитини», 2017
© Publisher Zaslavsky O.Yu., 2017 © Видавець Заславський О.Ю., 2017
For correspondence: Oleksandr Abaturov, MD, PhD, Professor, Head of the Department of pediatrics 1 and medical genetics, State Institution "Dnipropetrovsk medical academy of Ministry of Health of Ukraine', Vernadsky st., 9, Dnipro, 49044, Ukraine; e-mail: alexabaturov@i.ua
Для кореспонденци: Абатуров Олександр €вгенович, доктор медичних наук, професор, завщувач кафедри педетри 1 та медично!' генетики, ДЗ «Днтропетровська медична академю МОЗ УкраТни», вул. Вернадського, 9, м. Днтро, 49044, УкраТна; e-mail: alexabaturov@i.ua
104
Здоров'я дитини, p-ISSN 2224-0551, e-ISSN 2307-1168
Том 12, № 2, 2017
KAiHNHa negiaTpin / Clinical Pediatrics
LL-37 in blood serum is seen in a range of diseases, including inflammatory diseases of respiratory tracts [8, 9].
Defensin and cathelicidin output is strengthened by vitamin D [10]. Nowadays there is a proof, that 1,25(OH)2D regulates the efficiency of immunity response and has a anti-inflammatory action [11]. This way vitamin D strengthens organism's protection against bacterial infections [12]. A connection between vitamin D deficiency and the frequency of respiratory disease development was found [13, 14]. In V. Wayse and his coauthors' study (2004) a raise of severe infection of lower respiratory tracts development risk among children with subclinical vitamin D deficiency was shown [15].
The purpose: to determine intension of endogenic antimicrobial peptides among children of young age, children sick with pneumonia and factors, which affect it.
Materials and methods
We did a complex examination of204 children of age from two months to 3 years (an average age of patients was 1.6 ± 0.3 years), sick with pneumonia.
A mandatory complex of examination included chest organs roentgenography, a general blood test examination, general urinalysis, microbial examination of oral swab. Examination of microbial spectrum of tunica mucosa biomaterial was conducted before the antimicrobial therapy was prescribed when the child was directed to the in-patient hospital on a bacteriological analyzer VTTEK 2 Compact (BioMerieux, France) with the use of AES software: Global CLST-based + Phenotypic. Pj-defensins content in blood serum was examined with immune enzymometric analysis with the use of commercial kit Defensin Beta 1 (Elisa, Germany). The exa-mination of cathelicidin level LL-37 was conducted by the immune en-zymometric analysis with the use of commercial kit LL-37 (Hyculbiotech, Netherlands). The examination of 25-hy-droxyvitamin D was conducted by TFA with the help of commercial kit IDS OSTEIA 25-Hydroxy Vitamin D test. The control group included 17 healthy children, resemblant by age.
Received results were processed by the method of variation statistics with the usage of analysis package program Statistica for Windows 6.0 with calculating of arithmetical mean (M), standard deviation (a) and average mistakes (m). To evaluate difference in measurements in comparable groups we used Student's t-test. The differences were considered meaningful, if p < 0.05.
Results
Considering that the main ways of lower respiratory tracts infection of children in young age are oral aspiration and breathing in microbial aerosol, and also, given information from the literature that the respiratory microflora has the same structure, and biomass of which is decreasing from upper to lower tract [16, 17], we did an analysis of oral microbiological "scenery" features of children in young age, who are sick with out of hospital pneumonia. According to the results of microbiological examination we established diagnostically meaningful colonization of upper respiratory tracts by pathogenic microflora with 124 (60.8 %) out of 204 kids (fig. 1). Microflora that was dominating among children who were
Figure 1. Microflora structure, selected from oral swab from children of young age, who were sick with out-of hospital pneumonia
sick with out-of hospital pneumonia, was Streptococcus pneumoniae — 75 children (36.8 %). Almost six times less we saw gramnegative bacteria Klebsiella pneumoniae — 14 patients (6.9 %) and Haemophilus influenzae — 13 kids (6.4 %). Other origins were seen in rare cases.
According to this, children of young age, who were sick with out-of hospital pneumonia, had colonization of upper respiratory tracts by Streptococcus pneumoniae bacteria.
It is well-known, that Streptococcus pneumoniae is facultative origin, which inhabits nasopharynx of a person, where it is exposed to a set of antimicrobial peptides, which are a part of innate immunity response. Antimicrobial peptides connect with negatively charged tei-choic acids on the membranes of Gram-positive bacteria through electrostatic interaction, which leads to the lysis of microbial cells, creating a first line of defense [18, 19]. That's why it is possible that the susceptibility of strains of Streptococcus pneumoniae to antimicrobial peptides has a certain role in determining their ability to colonize [20].
So the next step of our work was to determine endogenous antimicrobial peptides in the blood serum of 20 infants, sick with out-of hospital with pneumonia (tab. 1).
Table 1. Contents of endogenous antimicrobial peptides in the blood serum of 20 infants, sick with pneumonia (M ± m)
Indicator Sick with pneumonia, n = 20 The Control group, n = 17
ß1-defensin, pg/ml 100.7 ± 18.2 123.6 ± 15.9
LL-37, ng/ml 0.10 ± 0.01* 0.30 ± 0.08
25(OH)D, mME/ml 75.0 ± 10.0* 104.8 ± 6.7
Note: * — p < 0.05 — in comparison to the control group.
The choice of Pj-defensins as a subject of our research is because it is the main factor of innate immunity and so, the antimicrobial barrier system MALT. Defensins take part in all the phases of lungs response, including the initial pathogen destruction. The peptide Pj-defensins predominantly shows activity regarding Moraxella catarrha-lis and Streptococcus pneumoniae, as well as has a special meaning in avoiding transition of commensal bacteria to opportunistic pathogens [21].
TOM 12, № 2, 2017
www.mif-ua.com,http://childshealth.zaslavsky.com.ua
105
KAiHNHa negiaTprn / Clinical Pediatrics
The study of Pj-defensins content in blood serum of infants, sick with out-of hospital pneumonia, showed the presence of tendency to reduction of it's level compared to control group (tab. 1). It is possible, that the received result is conditioned by wide cconstitutively expression Pj-defensins with the help of epithelial cells and takes part in innate antimicrobial protection. At the same time, the induction of expression of specified antimicrobial peptide because of inflammatory stimulus is barely happening [22]. Moreover, if other defensins can directly recognize specific lipids in the pathogen membranes [23, 24], then Pj-defensin becomes active only when conformation changes after the reduction of its disulfide bonds [25, 26]. In addition, the production of Pj-defensin in the epithelial cells of respiratory tracts is reducing in the condition of acidosis [27], which naturally is developed among children, sick with pneumonia [28].
In the course of further work, we investigated the content in the blood serum of children who were under observation, catelicidin LL-37. The multifunctional role of LL-37 is realized due to its ability to recognize and interact with various molecular targets and immune cells [22]. In addition, LL-37 modulates innate immunity by stimulating macrophages to phagocytic bacteria [29]. In addition to antimicrobial activity, LL-37 also activates mechanical features, such as permeability and bacterial uptake by epithelial cells [4].
As a result of the study, it was found that the LL-37 content in the group of infants with out-of hospital pneumonia was 3 times lower than the control group. The lowest values of LL-37 were found in children with pneumo-coccal pneumonia. It is possible to assume that a decrease in the content of LL-37 in the blood serum of infants is one of the main causes of increased susceptibility to Streptococcus pneumoniae. One possible factor contributing to the decrease in LL-37 activity is that the cations of specific antimicrobial peptide interact with mucin anions, which is a component of airway mucus, resulting in a decrease in the antimicrobial activity of LL-37 [30]. It was found that LL-37 induces the virulence of Streptococcus of group A due to increased production of virulence factors, which is mediated by the component of the regulatory system CsrRS [31]. In year 2014 J.J. Velarde and coauthors identified the smallest fragment of LL-37-RI-10 required for binding to CsRS. This fragment can directly bind to the sensory kinase CsrS, which leads to the activation of expression of virulence factors of the microorganism [32]. It was previously found that such a peptide does not possess antibacterial activity [33, 34]. In the opinion of I. Gryl-los and coauthors (2008), LL-37 has a paradoxical effect, stimulating the regulated CsrRS expression of the virulence gene, thereby increasing the pathogenicity of group A Streptococcus during an infectious disease. The ability of Streptococcus of group A to perceive and respond to LL-37 may partially explain the susceptibility of humans as a biological species not only to Streptococcus of group A, but also to streptococcal infection in general [31]. Based on the data obtained, it was suggested that in the conditions of LL-37 deficiency an inversion of its action is observed, that is, instead of the expected bactericidal effect, the virulence of the microorganism increases [35].
An additional factor that may influence the expression and activity of LL-37 may be metabolic or respiratory-metabolic acidosis. Abou Alaiwa and coauthors (2014) showed that the antibacterial activity of LL-37 depends on the pH of the airways. At the same time, a decrease in pH from 8 to 6,8 in the airways reduces the activity of LL-37 [36]. It is known that pH modulates the state of human oligo-merization of LL-37. At acid pH, LL-37 is monomelic, at physiological pH cathecidin aggregates [37]. In the work of Singh, D. and coauthors (2014), it was found that the enhancement of LL-37 signal transduction by the Toll-like receptor 3 (TLR3) is regulated by pH [38]. Upon acidification by endosomes, the oligomerized LL-37 dissociates into LL-29 (a natural LL-37 fragment lacking the C-terminal part) [39], which is unable to transmit TLR3 signals [38]. In this case, inhibition of cathepsins, which includes proteases, whose activity is activated by endosome acidification, resulted in an increase in the half-life of LL-37 from cells [38].
Discussion
It is known that vitamin D plays an important role in regulating LL-37 expression. Respiratory epithelial cells convert vitamin D into its active metabolite calcitriol, which has a 100 times greater affinity for the vitamin D receptor than calcidiol [40]. The process of formation of calcitriol is catalyzed by the enzyme aj -hydroxylase, that is present in the mitochondria of renal tubular cells [41]. The interaction of calcitriol with epithelial cells of the respiratory tract leads to active synthesis of catelicidin protein, which prevents penetration of pathogens into the lower respiratory tract [40].
In the works of P.T. Liu and coauthors (2006) describes the vitamin-D-dependent pathway of the TLR2/1-asso-ciated pathway for the synthesis of antimicrobial peptides. It has been shown that activation of human macrophage TLR with increased expression of the vitamin D receptor, promotes the induction of LL-37 expression. According to the authors, the findings confirm the relationship between TLR and vitamin D-mediated congenital immunity and suggest that differences in a person's ability to produce vitamin D affect susceptibility to microbial infection [42]. It was shown by the researchers from New Zealand (2011), that in patients with pneumonia, severe 25-hydroxyvitamin D-deficiency (< 30 nmol/L) correlated closely with a higher 30-day mortality compared to patients with a sufficient level (> 50 nmol/L) [43].
Considering that the low level of vitamin D supply is associated with a high risk of developing respiratory tract infections [44, 45], the next step of our work was to determine the content of vitamin D metabolites in the serum of children in the observation groups (tab. 1).
The analysis of the content of vitamin D metabolites in blood serum showed that among children, sick with out-of hospital pneumonia, the concentration of 25-hyd-roxyvitamin D was 1.4 times lower than in healthy children and averaged 75.0 ± 10.0 mIU/ml vs 104.8 ± ± 6.7 mIU/ml, accordingly (p < 0.05). Taking into account that vitamin D induces LL-37 expression; we determined the ratio of LL-37 to 25-hydroxyvitamin D. It was found that in the group of children with pneumonia, a 3.7-fold decrease
106
3gopoB'q amti/ihi/i, p-ISSN 2224-0551, e-ISSN 2307-1168
TOM 12, № 2, 2017
in the percentage of LL-37 in relation to vitamin D (0.12 ± ± 0.04 % against 0.44 ± 0.12 %, accordingly, p < 0.05). So, on the background of low levels of vitamin D among children with pneumonia, there was not enough LL-37 synthesis.
One of the pathogenetic mechanisms for reducing cal-citriol levels is a decrease in the activity of 1a-hydroxylase [46]. In numerous experimental studies, it was shown that the development of metabolic acidosis suppresses the synthesis of 25-hydroxyvitamin D3-1a-hydroxylase in the proximal tubules of the kidneys by inhibiting parathyroid hormone-dependent adenylate cyclase, which leads to a decrease in serum vitamin D levels [47—49] and , as a consequence, a decrease in the synthesis of LL-37 [50].
Conclusions
1. The development of out-of hospital pneumonia among infants occurs at the background of a low blood serum level of a number of endogenous antimicrobial peptides (Pj-defensin and LL-37).
2. A significant pathogenetic factor of the deficiency of cathelicidin LL-37 in the blood serum of infants with out-of hospital pneumonia is the deficiency of vitamin D metabolites.
Conflicts of interests. Authors declare the absence of any conflicts of interests that might be construed to influence the results or interpretation of their manuscript.
References
1. Mcintosh K Community-acquired pneumonia in children. New England Journal ofMedicine. 2002;346(6):429-37. doi: 10.1056/ NEJMra011994.
2. World Health Organization (WHO). Pneumonia fact sheet. Fact sheet 331. Reviewed September 2016. Available at: www.who.int/media-centre/factsheets/fs331/en/.
3. Wu Rui-Qing, Dun-Fang Zhang, Eric Tu, et al. The mucosal immune system in the oral cavity — an orchestra of T cell diversity. Int J Oral Sci. 2014Sept;6(3):125-32. PMC4170154. doi:10.1038/ijos.2014.48.
4. Tyrnova EV, Aleshina GM, Yanov YuK, Kokryakov VN. Ekspres-siya genovв -defensinov-1 i -2 i katelitsidina LL-37 v slizistoy dykhatel-nykh putey. Otsenka ekspressii genov beta-defensinov-1 i -2 cheloveka i katelitsidina LL-37 v slizistoy obolochke verkhnikh dykhatelnykh putey [Expression of the p-defensin-1 and -2 and catelicidin LL-37 in the respiratory mucosa. Estimation of human beta-defensins-1, 2 and cathelicidin LL-37 genes expression in the upper airway mucosa]. Tsitokiny i vospaleniye. 2014;13( 2):89-95. (in Russian).
5. Aleshina GM, Kokryakov VN, Shamova OV. Covremennaya kont-septsiya ob antimikrobnyih peptidah kak molekulyarnyih faktorah immunite-ta [Modern concept of antimicrobial peptides as molecularfactors of immunity]. Meditsinskiy akademicheskiy zhurnal. 2010;4:149-60. (in Russian).
6. Hiemstra PS, Amatngalim GD, van der Does AM, Taube C. Antimicrobial Peptides and Innate Lung Defenses: Role in Infectious and Noninfectious Lung Diseases and Therapeutic Applications. Chest. 2016;149(2):545-51. PMID: 26502035. doi:10.1378/chest.15-1353.
7. Miroshnichenko YuA, ShestopalovAV, Smolyaninova LP. Rol fakto-rov vrozhdennogo immuniteta slizistoy obolochki reproduktivnogo trakta [The role offactors of congenital immunity of the mucous membrane of the reproductive tract]. Zhurnal fundamentalnoy meditsinyi i biologii. 2013;1:S11.
8. ZasloffM. Antimicrobial peptides of multicellular organisms. Nature. 2002;415(6870):389-95. PMID: 11807545. doi:10.1038/415389a.
9. Zaiou М, Nizet V, Gallo RL. Antimicrobial and Protease Inhibitory Functions of the Human Cathelicidin (hCAP18/LL-37) Prosequence. The Journal of Investigative Dermatology. 2003;120(5):810—6. PMID: 12713586. doi:1523-1747.2003.12132.x.
10. Hansdottir S, Monick MM, Hinde SL. Respiratory epithelial cells convertinactive vitamin D toits active form: potential effects on hostdefense. J Immunol. 2008Nov 15;181(10):7090-9. PMID: 18981129. doi: 10.4049/ jimmunol.181.10.7090.
11. Zaharova IN, Yablochkova SV, Dmitrieva YuA. Izvestnyie i neiz-vestnyie effekty ivitamina D [Well-known and Indeterminate Effects of Vita-
min D]. Voprosyi sovremennoy pediatrii. 2013;2:20-25. doi: 10.15690/vsp. v12i2.616 (in Russian).
12. Gorgoni B, MaritanoD, Marthyn P. C/EBP beta gene inacti-vation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages. Journal of Immunology. 2002;168(8):4055-62. PMID: 11937564. doi: 10.4049/jimmu-nol.168.8.4055.
13. Yim S, Dhawan P, Ragunath C, et al. Induction of cathelicidin in normaland CF bronchial epithelial cells by 1,25 dihydroxy Vitamin D3. Journal of Cystic Fibrosis. 2007Nov 30;6(6):403-10. PMID: 17467345. doi: 10.1016/j.jcf2007.03.003.
14. Belderbos ME, Houben ML, Wilbrink B. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics. 2011;127(6):1513-20. PMID: 21555499. doi: 10.1542/peds.2010-3054.
15. Wayse V, Yousafzai A, Mogale K, Filteau S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur J Clin Nutr. 2004Apr;58(4):563-7. PMID: 15042122. doi: 10.1038/sj.ejcn.1601845.
16. Pikuza OI, Samorodnova EA. Sovremennyie osobennosti vnebol-nichnyih pnevmoniy u detey rannego vozrasta [Contemporary pecularities of community-acquired pneumonia in children of tender age]. Prakticheskaya meditsina. 2013;6(75):35-41. (in Russian).
17. Charlson ES, Bittinger K, Haas AR.. Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract. Amer J Respir And Crit Care Med. 2011;184(8):957-63. PMID: 21680950. doi:10.1164/rccm.201104-0655OC.
18. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005 Mar;3(3):238-50. PMID: 15703760. doi:10.1038/nrmicro1098.
19. Burton MF, Steel PG. The chemistry and biology of LL-37. Nat Prod Rep. 2009;26:1572-84. PMID: 19936387. doi:10.1039/b912533g.
20. Habets MG, Rozen DE, Brockhurst MA. Variation in Streptococcus pneumoniae susceptibility to human antimicrobial peptides may mediate intraspecific competition. Proc Biol Sci. 2012 Sep 22;279(1743):3803-11. PMID: 22764166. doi: 10.1098/rspb.2012.1118.
21. Abaturov AE, Gerasimenko ON, Vyisochina IL., Zavgorodnyaya NYu. Defenzinyi i defenzin-zavisimyie zabolevaniya [Defensins and defen-sin-dependent diseases]. Odessa: VMV; 2011.264p. (in Russian).
22. Doss M, White MR, Tecle T, Hartshorn KL. Human defen-sins and LL-37 in mucosal immunity. Journal of leukocyte biology. 2010 Jan;87(1):79-92. PMID: 19808939. doi: 10.1189/jlb.0609382.
23. De Medeiros LN, Angeli R, Sarzedas CG. Backbone dynamics of the antifungal Psd1 pea defensin and its correlation with membrane interaction by NMR spectroscopy. Biochim Biophys Acta. 2010 Feb;1798(2):105-113. PMID: 19632194. doi: 10.1016/j.bbamem.2009.07.013.
24. Shenkarev ZO, Gizatullina AK., Finkina EI. Heterologous expression and solution structure ofdefensin from lentil Lens culinaris. Biochem Biophys Res Commun. 2014;451:252-7. doi: 10.1016/j.bbrc.2014.07.104.
25. Schroeder BO, Wu Z, Nuding S, et al. Reduction ofdisulphide bonds un masks potent antimicrobial activity of human ß-defensin 1. Nature. 2011 Jan 20;469(7330):419-23. PMID: 21248850. doi: 10.1038/nature09674.
26. Raschig J, Mailänder-Sanchez, D, Berscheid A, et al. Ubiquitously expressed Human Beta Defensin 1 (hBD1) forms bacteria-entrapping nets in a redox dependent mode of action. PloS pathogens. 2017;13(3):S1006261. doi: 10.1371/journal.ppat.1006261.
27. Nakayama K, Jia YX, HiraiH. Acid stimulation reduces bactericidal activity of surface liquid in cultured human air way epithelial cells. American journal of respiratory cell and molecular biology. 2002;26(1):105-113. PMID: 11751210. doi: 10.1165/ajrcmb.26.1.4425.
28. Shabalov NP. Pnevmonii u detey rannego vozrasta [Pneumonia in young children]. Lechaschiy vrach. 2003;2:16-22. (in Russian).
29. Wan M, vander Does AM, Tang X, et al. Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages. J Leukoc Biol. 2014Jun;95(6):971-81. PMID:24550523. doi: 10.1189/jlb.0513304.
30.FelgentreffK, Beisswenger C, GrieseM,etal. The antimicrobial peptide cathelicidin interacts with airway mucus. Peptides. 2006Dec;27(12):3100-06. PMID: 16963160. doi: 10.1016/j.peptides.2006.07.018.
31. Gryllos I, Tran-Winkler HJ, Cheng MF, et al. Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci U. S. A. 2008;105(43):16755-60. PMID: 18936485. doi: 10.1073/ pnas.0803815105.
32. Velarde JJ, Ashbaugh M, Wessels MR. The human antimicrobial peptide LL-37 binds directly to CsrS, a sensor histidine kinase of group A Streptococcus, to active at expression of virulence factors. J Biol Chem. 2014 Dec 26;289(52):36315-24. PMID: 25378408. doi: 10.1074/jbc. M114.605394.
33. Wang G. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J. Biol. Chem. 2008;283:32637-43. PMID: 18818205. doi: 10.1074/jbc.M805533200.
Том 12, № 2, 2017
www.mif-ua.com,http://childshealth.zaslavsky.com.ua
107
34. Epand RF, Wang G, Berno B, Epand RM. Lipid segregation explains selective toxicity of a series offragments derivedfrom the human cathelicidin LL-37. Antimicrob Agents Chemother. 2009;53:3705-14. doi: 101128/AAC00321-09.
35. Wang G, Epand RF, Mishra B, et al. Decoding the functional roles ofcationic side chains of the major antimicrobial region of human cathelicidin LL-37. Antimicrob Agents Chemother-. 2012;56(2):845-56. doi: 10.1128/ AAC.05637-U.
36. Abou Alaiwa MH, Reznikov LR,, Gansemer ND, et al. pHmodulates the activity and synergis mofthe airway surface liquid antimicrobials beta-defensin-3 and LL-37. Proc Natl Acad Sci USA.. 2014 Dec 30;111(52): 18703-8. PMID: 25512526. doi: 10.1073/pnas.1422091112.
37. Johansson J, Gudmundsson GH, Rottenberg ME. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem. 1998 Feb 6;273(6):3718-24. PMID: 9452503. doi: 10.1074/jbc.273.6.3718.
38. Singh D, Vaughan R, Kao CC. LL-37 peptide enhancement of signal transduction by toll-like receptor 3 is regulated by pH: identification of a peptide antagonist of LL-37. J Biol Chem. 2014 Oct 3;289(40):27614-24. PMID: 25092290 doi: 10.1074/jbc.M114.582973.
39. Yamasaki K, SchauberJ, Coda A, et al. Kallikrein-mediatedproteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB Journal. 2006 0ct;20(12):2068-80. PMID:17012259. doi: 10.1096/fj.06-6075com.
40. Zaharova IN. Vitamin D: neizvestnoe ob izvestnom [Vitamin D: unknown about the known]. Rossiyskiy meditsinskiy zhurnal. 2015;3:S118. (in Russian).
41. Zaharova IN, Dmitrieva YuA, Yablochkova SV. Modern view on the metabolism and physiological effects of vitamin D in the human body. Vest-nik Almatinskogo gosudarstvennogo instituta usovershenstvovanija vrachej. 2013;2:27-31. (in Russian).
42. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006 Mar 24;311(5768):1770-3. PMID: 16497887. doi: 10.1126/science.1123933.
43. Leow L, Simpson T, Cursons R, Karalus N, Hancox RJ. Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology. 2011 May;16(4):611-6. PMID: 21244571. doi: 10.1111/j.1440-1843.2011.01924.x.
44. Laaksi I, Ruohola JP, Tuohimaa P. An association of serum vitamin D concentrations < 40 nmol/l with acute respiratory tract infection in young Finnishmen. Am J Clin Nutr. 2007Sep;86(3):714-7. PMID: 17823437. doi: 10.3390/nu5072502.
45. Karatekin G, Kaya A, Salihoglu O. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2009 Apr;63(4):473-7. PMID: 18030309. doi: 10.1038/sj.ejcn.1602960.
46. De Boer IH, Vitamin D and glucose metabolism in chronic kidney disease. Current opinion in nephrology and hypertension. 2008;17(6):566. doi: 10.1097/MNH.0b013e32830fe377.
47. Lee SW, Russell J, Avioli LV. 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol: conversion impaired by systemic metabolic acidosis. Science. 1977Mar 11;195(4282): 994-6. PMID: 841324. doi: 10.1126/science.841324.
48. Kawashima H, Kraut JA, Kurokawa K. Metabolic acidosis suppresses 25-hydroxyvitamin in D3-1alpha-hydroxylase in the rat kidney. Distinct site and mechanism of action. J Clin Invest. 1982 Jul;70(1):135-40. PMID: 6282936. doi: 10.1172/JCI110586.
49. Chan YL, Sardie E, Mason RS, Posen S. The effect of metabolic acidosis on vitamin D metabolism and bone histology in uremic rats. Calcif Tissue Int. 1985 Mar;37:158-64. PMID: 3924372. doi: 10.1007/BF02554835.
50. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007 Aug;179(4):2060-3. PMID: 17675463. doi: 10.4049/jimmu-nol.179.4.2060.
Отримано 23.03.2017 ■
Леженко Г.О.1, Абатуров О.е.2, Пашкова О.е.1, Крайня Г.В.1
1Запорiзький державний медичний у^верситет, м. Запоржжя, Украина
2ДЗ «Днпропетровська медична академiя», м. Днпро, Украина
Роль ендогенних антимкробних пепти^в у
Резюме. Проведено комплексне обстеження 204 дней вь ком вщ 2 мюящв до 3 ротв i3 позалшарняною пневмошею. Установлено, що в дней раннього вшу, хворих на позаль карняну пневмошю, провщним етюлопчним фактором е бактери Streptococcus pneumoniae (36,8 %). Вмют ендогенних антимшробних пептвддв визначено в сироватщ кровi 20 дней раннього вшу, хворих на позалшарняну пневмошю, та 17 дней групи контролю. Доведено, що розвиток поза-лшарняно! пневмони в дней раннього вшу вщбуваеться на фон зниження вмiсту в сироватщ кровi ßj-дефензину та кателщидину LL-37. Найбшьш низьы значення LL-37 були встановлеш в дней, хворих на пневмошю, виклика-
виникненн пневмони в д^ей раннього вку
ну Streptococcus pneumoniae. Проведений аналiз вмюту метаболтв вттамшу D у сироватщ кровi показав, що в дней, хворих на позалшарняну пневмошю, концентращя 25-гщ-роксивнамшу D була в 1,4 раза нижчою порiвняно зi здоро-вими диъми (р < 0,05). Установлений дефщит метаболтв внамшу D у дней раннього вшу, хворих на позалшарняну пневмошю, е значущим патогенетичним фактором дефь циту кателщидину LL-37 у сироватщ кров^ що пщтверджу-валося зниженням у данш когорта хворих в 3,7 раза процентного вмiсту LL-37 щодо метаболтв внамшу D. Krn40Bi слова: позалшарняна пневмошя; ßj-дефензин; ка-телщидин LL-37; 25-гщроксивиамш D; дни раннього вшу
Леженко Г.А.1, Абатуров А.Е.2, Пашкова Е.Е.1, Крайняя А.В.1
1Запорожский государственный медицинский университет, г. Запорожье, Украина 2ГУ «Днепропетровская медицинская академия», г. Днепр, Украина
Роль эндогенных антимикробных пептидов в возникновении пневмонии у детей раннего возраста
Резюме. Проведено комплексное обследование 204 детей в возрасте от 2 месяцев до 3 лет с внебольничной пневмонией. Установлено, что у детей раннего возраста, больных внеболь-ничной пневмонией, ведущим этиологическим фактором являются бактерии Streptococcus pneumoniae (36,8 %). Содержание эндогенных антимикробных пептидов определено в сыворотке крови 20 детей раннего возраста, больных внеболь-ничной пневмонией, и 17 детей группы контроля. Доказано, что развитие внебольничной пневмонии у детей раннего возраста происходит на фоне снижения содержания в сыворотке крови ßj-дефензина и кателицидина LL-37. Наиболее низкие значения LL-37 были установлены у детей, больных пневмонией, вызванной Streptococcus pneumoniae. Проведенный ана-
лиз содержания метаболитов витамина D в сыворотке крови показал, что у детей, больных внебольничной пневмонией, концентрация 25-гидроксивитамина D была в 1,4 раза ниже по сравнению со здоровыми детьми (р < 0,05). Установленный дефицит метаболитов витамина D у детей раннего возраста, больных внебольничной пневмонией, является значимым патогенетическим фактором дефицита кателицидина ЕЬ-37 в сыворотке крови, что подтверждалось снижением в данной когорте больных в 3,7 раза процентного содержания ЕЬ-37 по отношению к метаболитам витамина D. Ключевые слова: внебольничная пневмония; Р1-дефен-зины; кателицидин ЕЬ-37; 25-гидроксивитамин D; дети раннего возраста
108
Здоров'я дитини, p-ISSN 2224-0551, e-ISSN 2307-1168
Том 12, № 2, 2017
